Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma

NCT02733809 is registered in ClinicalTrials.gov with King Saud University as lead sponsor.

NCT NCT02733809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02733809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
King Saud University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma